๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase I trial of marcellomycin with a weekly dose schedule

โœ Scribed by Joss, Rudolf A.; Kaplan, Shoshanna; Goldhirsch, Aron; Varini, Marco; Brunner, Kurt W.; Cavalli, Franco

Book ID
122391255
Publisher
Elsevier Science
Year
1983
Weight
526 KB
Volume
19
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase i-ii study of maytansine utilizi
A phase i-ii study of maytansine utilizing a weekly schedule
โœ Roman Franklin; Michael K. Samson; Roberto J. Fraile; Hakam Abu-Zahra; Robert O' ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 428 KB ๐Ÿ‘ 2 views

Maytansine, a new ansa macrolide antitumor antibiotic, was administered to a total of 107 patients in a Phase 1-11 study. Dose-limiting toxic reactions which occurred at 0.75-1.0 mg/M' in both Phase I and I1 were neurologic and consisted primarily of lethargylweakness (a debilitation syndrome) and p

Phase I studies of trimetrexate using si
Phase I studies of trimetrexate using single and weekly dose schedules
โœ Susan D. Huan; Sewa S. Legha; Martin N. Raber; Irwin H. Krakoff ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer US ๐ŸŒ English โš– 592 KB

Trimetrexate (TMTX), a potent inhibitor of the enzyme dihydrofolate reductase, was shown to be more active than its analogue, Methotrexate, against murine and human tumor cell lines in vitro and in vivo. We conducted two sequential phase I studies using a single bolus injection of TMTX every 14 days